A viro-psycho-immunological disease-model of a subtype affective disorder

Pharmacopsychiatry

Volumn 31, Issue 3, 1998, Pages 77-82

  Dietrich, D E ^a   Schedlowski, M ^b   Bode, L ^c   Ludwig, H ^d   Emrich, H M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c ROBERT KOCH INSTITUTE   (Germany)

^d FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Affective disorders; Borna disease virus (BDV); Neuropsychiatric disorders; Psychoneuroimmunology

Indexed keywords

AFFECTIVE NEUROSIS; ARTICLE; BORNA DISEASE VIRUS; HUMAN; NEUROPATHOLOGY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; STRESS;

EID: 0031859166     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979305     Document Type: Article

References (76)

1. Ader, R., D. L. Felten, N. Cohen: Psychoneuroimmunology., 2nd edition, Academic Press, San Diego (1991)
2. Aggleton, J. P., M. Mishkin: The amygdala: sensory gateway to the emotions. In: R. Plutchik, H. Kellerman (eds.): Emotion: Theory, research and experience (Vol. 3). Academic Press, Orlando (1986) 281-299
3. Amsterdam, J. D., A. Winokur, W. Dyson, S. Herzog, F. Gonzales, R. Rott, H. Koprowski: Borna disease virus: a possible etiologic factor in human affective disorders? Arch. Gen. Psychiatry 42 (1985) 1093-1096
4. Amsterdam, J. D., G. Maislin, L. Potter, R. Giuntoli: Reduced rate of recurrent genital herpes infections with lithium carbonate. Psychopharmacology Bulletin 26 (1990a) 343-347
5. Amsterdam, J. D., C. Maislin, J. Rybakowski: A possible antiviral action of lithium carbonate in herpes simplex virus infections. Biological Psychiatry 27 (1990b) 447-453
6. Angst, J.: The course of major depression, atypical bipolar disorder, and bipolar disorder. In: Hippius, H., G. L. Klerman, N. Matussek (eds.): New results in depression research. Springer, Berlin, Heidelberg, New York, London, Paris, Tokyo (1986) 26-35
7. Benschop, R. J., R. Jacobs, B. Sommer, T. H. Schürmeyer, H. R. Raab, R. E. Schmidt, M. Schedlowski: Modulation of the immunologic response to acute stress in humans by beta-blockade and benzodiazepines. FASEB J. 10 (1996) 517-524
8. Besedovsky, H. O., A. del Rey: Immuno-neuro-endocrine interactions: facts and hypotheses. Endocrine Rev. 17 (1996) 1-39
9. Bode, L.: Human infections with Borna disease virus and potential pathogenic implications. Curr. Top. Microbiol. Immunol. 190 (1995) 103-130
10. Bode, L., S. Riegel, W. Lange, H. Ludwig: Human infections with Borna disease virus: seroprevalence in patients with chronic diseases and healthy individuals. J. Med. Virol. 36 (1992) 309-315
11. Bode, L., F. Steinbach, H. Ludwig: A novel marker for Borna disease virus infection. Lancet 343 (1994) 297-298
12. Bode, L., W. Zimmermann, R. Ferszt, F. Steinbach, H. Ludwig: Borna disease virus genome transcribed and expressed in psychiatric patients. Nature Med. 1 (1995) 222-236
13. Bode, L., R. Dürrwald, F. A. Rantam, R. Ferszt, H. Ludwig: First isolates of infectious human Borna disease virus from patients with mood disorders. Molecular Psychiatry 1 (1996) 200-212
14. Bode, L., H. Ludwig: Bornavirus-lnfektion und psychiatrische Erkrankungen. Z. Allg. Med. 73 (1997 a) 621-627
15. Bode, L., H. Ludwig: Clinical similarities and close genetic relationship of human and animal Borna disease virus. Arch. Virol. (Suppl.) 13 (1997 b) 167-182
16. Bode, L., D. E. Dietrich, R. Stoyloff, H. M. Emrich, H. Ludwig: Amantadine and human Borna disease virus in vitro and in an infected patient with bipolar depression. Lancet 349 (1997) 178-179
17. Buchwald, D., M. H. Wener, T. Pearlman, P. Kith: Markers of inflammation and immune activation in chronic fatigue and chronic fatigue syndrome. J. Rheumatol. 24:2 (1997) 372-376
18. Bunney, W. E. Jr., J. M. Davis: Norepinephrine in depressive reactions: a review. Archives of General Psychiatry 13 (1965) 483-494
19. Caldwell, C. L., M. Irwin, J. Lohr: Reduced natural killer cell cytotoxicity in depression but not in schizophrenia. Biol. Psychiat. 30 (1991) 1131-1138
20. Caroll, B. J., G. C. Curtis, J. Mendels: Neuroendocrine regulation in depression: II. Discrimination of depressed from nondepressed patients. Arch. Gen. Psychiatry 33 (1976) 1051-1058
21. Charney, D. S., S. M. Southwick, P. L. Delgado, J. H. Krystal: Current status of the receptor sensitivity hypothesis of antidepressant action: Implications for the treatment of severe depression. In: J. D. Amsterdam (ed.): Pharmacotherapy of depression. Marcel Dekker, Basel (1990) 13-34
22. Checkley, S.: Neuroendocrinology. In: Paykel, E. S. (ed.): Handbook of Affective Disorders. The Guilford Press, New York, London (1992) 255-266
23. Cohen, S., G. M. Williamson: Stress and infectious disease in humans. Psychol. Bull. 109 (1991) 5-24
24. Connor, T. J., B. E. Leonard: Depression, stress and immunological activation: The role of cytokines in depressive disorder. Life Sciences 62 (1998) 583-606
25. Coppen, A.: The biochemistry of affective disorders. Brit. J. Psychiatry 113 (1967) 1237-1264
26. Davis, M.: The role of the amygdala in fear potentiated startle: implications for animal models of anxiety. TiPS 13 (1992) 35-40
27. Dietrich, D. E., L. Bode, H. Ludwig, C. W. Spannhuth, H. M. Emrich: Therapeutische Implikationen der Borna Disease Virus (BDV)-Infektion bei affektiven Erkrankungen. In: Marneros, A., P. Brieger: Psychiatrie als Therapiefach. S. Roderer Verlag, Regensburg (197) 153-158
28. Dittrich, W., L. Bode, H. Ludwig, et al.: Learning deficiencies in Borna disease virus-infected but clinically healthy rats. Biol. Psychiatry 26 (1989) 818-828
29. Emrich, H. M., M. Dose, D. v. Zerssen: The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders. J. Affect. Dis. 8 (1985) 243-250
30. Emrich, H. M.: Alternatives to lithium prophylaxis for affective and schizoaffective disorders. A. Marneros, M. T. Tsuang (eds.): Affective and Schizoaffective Disorders. Springer, Berlin (1990) 262-273
31. Emrich, H. M., M. Dose, R. Wolf: The action of mood-stabilizers in affective disorders: An integrative view as a challenge. Neuropsychobiology 27 (1993) 158-162
32. Glaser, R., G. R. Pearson, J. F. Jones, J. Hillhouse, S. Kennedy, H. Mao, J. K. Kiecolt-Glaser: Stress-related activation of Epstein-Barr virus. Brain, Behavior, and Immunity 5 (1991) 219-232
33. Glaser, R., W. P. Lafuse, R. H. Bonneau, C. Atkinson, J. K. Kiecolt-Glaser: Stress-associated modulation of proto-oncogene expression in human peripheral blood leucocytes. Behav. Neuroscience 107 (1993) 525-529
34. Goodwin, F. K., K. R. Jamison: Manic-depressive illness. Oxford University Press, New York, Oxford (1990)
35. Gosztonyi, C., H. Ludwig: Neurotransmitter receptors and viral neurotropism. Neuropsychiat. Clin. 3 (1984) 107-114
36. Gosztonyi, G., H. Ludwig: Borna disease-neuropathology and pathogenesis. Curr. Top. Microbiol. Immunol. 190 (1995) 39-64
37. Hartley, C. E., A. Buchan, S. Randall, G. R. Skinner, M. Osborne, L. M. Tomkins: The effects of lithium and potassium on macromolecular synthesis in herpes simplex virus-infected cells. J. Gen. Virol. 74 (1993) 1519-1525
38. Huber, T. J., D. E. Dietrich, H. M. Emrich: Amantadine in Affective Disorders (submitted)
39. Irwin, M., T. Patteron, T. L. Smith, C. Caldwell, S. A. Brown, J.-C. Gillin, I. Grant: Reduction of immune function in life stress and depression. Biol. Psychiatry 27 (1990) 22-30
40. Irwin, M., M. Brown, T. Patterson, R. Hauger, A. Mascovich, I. Grant: Neuropeptide Y and natural killer cell activity: Findings in depression and Alzheimer cargiver stress. FASEB J. 5 (1991) 3100-3107
41. Irwin, M., U. Lacher, C. Caldwell: Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol. Med. 22 (1992) 1045-1050
42. Janowski, D. S., M. K. El-Yousef, J. M. Davis, H. J. Sekerke: A cholinergic adrenergic hypothesis of mania and depression. Lancet 2 (1972) 632-635
43. Kiecolt-Glaser, J. K., R. Glaser: Psychosocial influences on herpes virus latency. In: E. Kurstak, Z. J. Lipowski, P. V. Morzov (eds.): Viruses, immunity, and mental disorders. Plenum Press, New York (1987)
44. Kiecolt-Glaser, J. K., R. Glaser, S. Gravenstein, W. B. Malarkey, J. Sheridan: Chronic stress alters the immune response to influenza virus vaccine in older adults. Medical Sciences 93 (1996) 3043-3047
45. King, D. J., S. J. Cooper: Viruses, immunity and mental disorder. Brit. J. Psychiat. 154 (1989) 1-7
46. Lapin, I. P., G. F. Oxenkrug: Intensification of the central serotonergic processes as a possible determinant of the thymoleptic effect. Lancet 1 (1969) 132-136
47. Laudenslager, M. L.: Psychosocial stress and susceptibility to infections disease. In: E. Kurstak, Z. J. Lipowski, P. V. Morozov (eds.): Viruses, immunity, and mental disorders. Plenum Press, New York (1987)
48. Leserman, J., J. M. Petitto, D. O. Perkins, J. D. Folds, R. N. Golden, D. L. Evans: Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. Arch Gen Psychiatry 54 (1997) 279-285
49. Lipkin, W. I., K. M. Carbone, M. C. Wilson, C. S. Duchala, O. Narayan, B. A. Oldstone: Neurotransmitter abnormalities in Borna disease. Brian. Res. 475 (1988) 366-370
50. Ludwig, H., W. Kraft, M. Kao, G. Gosztonyi, E. Dahme, H. Krey: Borna-Virus-Infektion (Borna-Krankheit) bei natürlich und experimentell infizierten Tieren: Ihre Bedeutung für Forschung und Praxis. Tierärztliche Praxis 13 (1985) 421-453
51. Ludwig, H., L. Bode, G. Gosztonyi: Borna disease: a persistent virus infection of the central nervous system. Prog. Med. Virol. 35 (1988) 107-151
52. Ludwig, H., K. Furuya, L. Bode, N. Klein, R. Dürrwald, D. S. Lee: Biology and neurobiology of Borna disease viruses (BDV), defined by antibodies, neutralizability and their pathogenetic potential. Arch. Virol. (Suppl.) 7 (1993) 111-133
53. Ludwig, H., L. Bode: The neuropathogenesis of Borna disease virus infections. Intervirology 40 (1997) 185-197
54. Madden, K. S., D. L. Felten: Experimental basis for neural-immune interactions. Physiol. Rev. 75 (1995) 77-106
55. Maes, M., J. Lambrechts, E. Bosmans, J. Jacobs, E. Suy, C. Vandervorst, C. de Jonckheere, B. Minner, J. Raus: Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychological Medicine 22 (1992) 45-53
56. Maes, M., R. Smith, S. Scharpe: The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20 (1994) 111-116
57. Maes, M., I. De Meester, R. Verkerk, P. De Medts, A. Wauters, G. Vanhoof, E. Vandoolaeghe, H. Neels, S. Scharpé: Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: Relationships with immune-inflammatory markers. Psychoneuroendocrinology 22 (1997) 65-78
58. Müller, N.: Die Rolle des Zytokinnetzwerks im ZNS und psychische Störungen. Nervenarzt 68 (1997) 11-20
59. Nurnberger, J. I. Jr., E. S. Gershon: Genetics. In: Paykel, E. S. (ed.): Handbook of affective disorders. The Guilford Press, New York, London (1992) 131-148
60. Murray, R. M., P. Jones, E. O'Callaghan, N. Takei, P. Sham: Genes, viruses and neurodevelopmental schizophrenia. J. Psychiat. Res. 26 (1992) 225-235
61. Paykel E. S., Z. Cooper: Live events and social stress. In: Paykel, E. S. (ed.): Handbook of affective disorders. The Guilford Press, New York, London (1992) 149-170
62. Reichlin, S.: Neuroendocrine-immune interactions. New Engl. J. Med. 329 (1993) 1246-1253
63. Rott, R., S. Herzog, B. Fleischer, A. Winokur, J. Amsterdam, W. Dyson, H. Koprowski: Detection of serum antibodies to borna disease virus in patients with psychiatric disorders. Science 228 (1985) 755-756
64. Sachar, E. J.: Hormonal changes in stress and mental illness. In: D. T. Krieger, J. C. Hughes (eds.): Neuroendocrinology. Sunderland, MA: Sinauer & Associates (1980) 129-135
65. Schedlowski, M., R. Jacobs, G. Stratmann, S. Richter, A. Hädicke, U. Tewes, T. O. F. Wagner, R. E. Schmidt: Changes of natural killer cells during acute psychological stress. J. Clin. Immunol. 13 (1993) 119-126
66. 2-adrenergic mechanisms. J. Immunol. 156 (1996) 93-99
67. Schildkraut, J. J.: The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry 122 (1965) 509-522
68. Schwaninger, M., M. Weisbrod, W. Knepel: Progress in defining the mechanism of action of antidepressants. Pharmacol. Pathophysiol. 3 (1997) 237-243
69. Seidel, A., V. Arolt, M. Hunstiger, L. Rink, A. Behnisch, H. Kirchner: Cytokine production and serum proteins in depression. Scan. J. Immunol. 41 (1995) 534-538
70. Seidel, A., V. Arolt, M. Hunstiger, L. Rink, A. Benisch, H. Kirchner: Increased CD56 + natural killer cells and related cytokines in major depression. Clin. Immunol. Immunopathol. 78 (1996) 83-85
71. Sprankel, H., K. Richarz, H. Ludwig, R. Rott: Behavior alterations in tree shrews (Tupaia glis) induced by Borna disease virus. Med. Microbiol. Immunol. 165 (1978) 1-18
72. Stein, M., A. H. Miller, R. L. Trestman: Depression and the immune system. In: R. Ader, D. L. Felten, N. Cohen (eds.): Psychoneuroimmunology, 2nd edition, Academic Press, San Diego (1991)
73. Stitz, L., H. Krey, H. Ludwig: Borna disease in rhesus monkeys as a model for uveo-cerebral symptoms. J. Med. Virol. 6 (1980) 333-340
74. Vale, S., M. A. Espejel, J. C. Dominguez: Amantadine in depression. Lancet, August 21 (1971) 437
75. Weisse, C. S.: Depression and immunocompetence: A review of the literature. Psychol. Bull. 111 (1992) 475-489
76. Whybrow, P. C., A. J. Prange: A hypothesis of thyroid catecholamine receptor interaction. Arch. Gen. Psychiatry 38 (1981) 106-113